IP Verse

Nutritional Composition Comprising 2'Fucosyllactose And Dietary Butyrate - EP3883393

The patent EP3883393 was granted to Nutricia on Sep 7, 2022. The application was originally filed on Jun 4, 2020 under application number EP20730042A. The patent is currently recorded with a legal status of "Granted And Under Opposition".

EP3883393

NUTRICIA
Application Number
EP20730042A
Filing Date
Jun 4, 2020
Status
Granted And Under Opposition
Aug 5, 2022
Publication Date
Sep 7, 2022
External Links
Slate, Register, Google Patents

Patent Summary

Patent Family

Patent Family

Patent Oppositions (4)

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentativeOpposition Status

Get instant alerts for new oppositions and patent status changes

ABBOTTJun 6, 2023BOULT WADE TENNANTADMISSIBLE
NESTLEJun 6, 2023STRYCHADMISSIBLE
RECKITT BENCKISERJun 6, 2023CURRANADMISSIBLE
FRIESLANDCAMPINA NEDERLANDJun 2, 2023FRIESLANDCAMPINA DEPARTMENTADMISSIBLE

Patent Citations (34) New

Patent citations refer to prior patents cited during different phases such as opposition or international search.

Citation PhasePublication Number
DESCRIPTIONEP0778885
DESCRIPTIONFR2723960
DESCRIPTIONWO2004112509
DESCRIPTIONWO2005122790
DESCRIPTIONWO2006115412
DESCRIPTIONWO2009151330
DESCRIPTIONWO2009151331
DESCRIPTIONWO2013187764
DESCRIPTIONWO2016013935
DESCRIPTIONWO9606924
INTERNATIONAL-SEARCH-REPORTCN107736614
INTERNATIONAL-SEARCH-REPORTUS2007104700
INTERNATIONAL-SEARCH-REPORTUS2012129935
INTERNATIONAL-SEARCH-REPORTUS2015064220
INTERNATIONAL-SEARCH-REPORTUS2017157242
INTERNATIONAL-SEARCH-REPORTUS2019029306
OPPOSITIONCN105532883
OPPOSITIONCN108450555
OPPOSITIONCN109315491
OPPOSITIONUS2017127693
OPPOSITIONUS2017157242
OPPOSITIONUS2018133235
OPPOSITIONUS2019029306
OPPOSITIONWO2006115412
OPPOSITIONWO2011008086
OPPOSITIONWO2012092160
OPPOSITIONWO2012158517
OPPOSITIONWO2015157098
OPPOSITIONWO2015164021
OPPOSITIONWO2016014473
OPPOSITIONWO2017114901
OPPOSITIONWO2018108841
OPPOSITIONWO2019008104
OPPOSITIONWO2020239722

Non-Patent Literature (NPL) Citations (53) New

NPL citations refer to non-patent references such as research papers, articles, or other publications cited during examination or opposition phases.

Citation PhaseReference Text
DESCRIPTION- AKBARI et al., Eur J Nutr., (20160000), vol. 56, no. 5, pages 1919 - 1930
DESCRIPTION- ALBERMANN et al., Carbohydrate Res, (20010000), vol. 334, pages 97 - 103
DESCRIPTION- ANDERSSONDONALD, J Chromatogr, (19810000), vol. 211, pages 170 - 1744
DESCRIPTION- LEFORESTIER, Eur J Nutr, (20090000), vol. 48, pages 457 - 464
DESCRIPTION- L. PROSKY et al., J. Assoc. Off. Anal. Chem., (19880000), vol. 71, pages 1017 - 1023
INTERNATIONAL-SEARCH-REPORT- KOBATA A, "Structures and application of oligosaccharides in human milk", PROCEEDINGS OF THE JAPAN ACADEMY. SERIES B, PHYSICAL ANDBIOLOGICAL SCIENCES, TOKYO, JP, (20100701), vol. 86, no. 7, doi:10.2183/PJAB.86.731, ISSN 0386-2208, pages 731 - 747, XP002612998 [A] 1-14 * tables 1,5 *
OPPOSITION- Anonymous, "2’-Fucosyllactose (3) - Assessment of substantial equivalence for a notification, in accordance with European Regulation 258/97 concerning novel foods and novel food ingredients ", CBG / MEB, (20171219), XP093248504
OPPOSITION- Anonymous, "2'-Fucosyllactose SD", BASF, (20181201), XP093248498
OPPOSITION- Anonymous, "COMPREHENSIVE GRAS ASSESSMENT Of the Proposed Uses of 2'-0-FUCOSYLLACTOSE", LSRO Solutions LLC; GRAS Notice (GRN) No. 749, (20171117), LSRO Solutions LLC; GRAS Notice (GRN) No. 749, URL: https://www.fda.gov/media/124475/download, (20240119), XP093121455
OPPOSITION- Anonymous, "First infant enrolled for the VOYAGE study", Internet citation, (20180906), pages 1 - 3, Internet citation, URL: https://www.danoneresearch.com/news/first-infant-enrolled-voyage-study/, XP093158377
OPPOSITION- Anonymous, "GRAS Notice (GRN) No. 650", FDA, (20160101), FDA, URL: https://www.fda.gov/media/99125/download, (20240119), XP093121730
OPPOSITION- Anonymous, "GRN No. 546", FDA, GRAS Notices, (20170517), FDA, GRAS Notices, URL: https://web.archive.org/web/20170517064904/https://www.accessdata.fda.gov/scripts/fdcc/index.cfm?set=GRASNotices&id=546, (20240119), XP093121524
OPPOSITION- Anonymous, "Milk, fat free (skim)", USDA, Survey (FNDDS), FDC ID: 2340765, Food Code: 11113000, (20221028), USDA, Survey (FNDDS), FDC ID: 2340765, Food Code: 11113000, URL: https://fdc.nal.usda.gov/fdc-app.html#/food-details/2340765/nutrients, (20240119), XP093121746
OPPOSITION- Anonymous, "Oli6 Dairy Goat Formula Range", Oli6, (20181123), Oli6, URL: https://web.archive.org/web/20181123150503/http://www.oli6.com.au/goats-milk-formula/, (20240119), XP093121518
OPPOSITION- Anonymous, "Oli6 Goat Milk Infant Formula", Oli6, (20190228), Oli6, URL: https://web.archive.org/web/20190228114119/https://www.oli6.com.au/shop/infant/, (20240119), XP093121494
OPPOSITION- Anonymous, "Oli6 Goat Milk Infant Formula", Oli6, (20190228), Oli6, URL: https://web.archive.org/web/20190228114119/https://www.oli6.com.au/shop/infant/, (20240119), XP093121496
OPPOSITION- Anonymous, "Oli6 Goat Milk Toddler Drink", Oli6, (20190302), Oli6, URL: https://web.archive.org/web/20190302004108/http://www.oli6.com.au/shop/toddler, (20240119), XP093121501
OPPOSITION- Anonymous, "Oli6 Natural Goat Milk Powder", Oli6, (20190313), Oli6, URL: https://web.archive.org/web/20190313002746/https://www.oli6.com.au/shop/oli6-natural-goat-milk-powder-suitable-people-1-year-old/, (20240119), XP093121512
OPPOSITION- Anonymous, Oli6, "Oli6 Goat Milk Follow on Formula", (20190228), URL: https://web.archive.org/web/20190228114300/https://www.oli6.com.au/shop/follow-on/, (20240119), XP093121497
OPPOSITION- Anonymous, "Pioneering innovations in early life nutrition for immunity through gu", Internet citation, (20170601), pages 1 - 7, Internet citation, URL: https://www.danoneresearch.com/pioneering-innovations-in-early-life-nutrition-for-immunity-through-gut/, XP093158446
OPPOSITION- Anonymous, "Safety and Tolerance of a Partly Fermented Infant Formula With Prebiotic Oligosaccharides in Healthy Infants (VOYAGE)", Cliniical Trials, (20180910), Database accession no. NCT03476889, XP093158451
OPPOSITION- Anonymous, "Science Review: 2’Fucosyllactose", Metagenics Institute, (20170101), Metagenics Institute, URL: https://www.metagenicsinstitute.com/wp-content/uploads/2018/01/2FL-Science-Review-US-CANADA-MET2443.pdf?utm_source=posts&utm_medium=PDF&utm_campaign=Science-Review&utm_content=2FL, (20240116), XP093119830
OPPOSITION- Blazquez, A.B. ; Knight, A.K. ; Getachew, H. ; Bromberg, J.S. ; Lira, S.A. ; Mayer, L. ; Berin, M.C., "A Functional Role for CCR6 on Proallergic T Cells in the Gastrointestinal Tract", Gastroenterology, W.B. Saunders, (20100101), vol. 138, no. 1, ISSN 0016-5085, pages 275 - 284.e4, XP026818327
OPPOSITION- D53d - Food Safety Authority of Ireland (FSAI), SUBSTANTIAL EQUIVALENCE OPINION,2’-O-Fucosyllactose from Food Safety Authority of Ireland (FSAI), 2016; (no date to be found on the paper)
OPPOSITION- D54 - Affidavit Sophie Nutten
OPPOSITION- Jennewein Stefan, "GRAS ASSESSMENT OF JENNEWEIN 2’-FL FOR USE IN HYPOALLERGENIC INFANT FORMULAS AND TODDLER FORMULAS, AND PRETERM INFANT FORMULAS ", FDA; GRAS Notice (GRN) No. 929, pages 1 - 2, FDA; GRAS Notice (GRN) No. 929 , URL: https://fda.report/media/142982/GRAS-Notice-GRN-929-2-Fucosyllactose.pdf, XP093248496
OPPOSITION- L Janský, P Reymanová, J Kopecký, "Dynamics of cytokine production in human peripheral blood mononuclear cells stimulated by LPS or infected by Borrelia", Physiological research / Academia Scientiarum Bohemoslovaca, Czech Republic, Czech Republic , pages 593 - 598, Physiological research / Academia Scientiarum Bohemoslovaca, URL: http://www.ncbi.nlm.nih.gov/pubmed/14535835, XP055135489
OPPOSITION- Minich Deanna, "The Benefits of Butter: A Rich Source of Butyrate", (20180723), URL: https://deannaminich.com/the-benefits-of-butter-a-rich-source-of-butyrate/, (20240116), XP093119828
OPPOSITION- Andrea Bedford, Gong Joshua, "Implications of butyrate and its derivatives for gut health and animal production", Animal Nutrition, (20180601), vol. 4, no. 2, doi:10.1016/j.aninu.2017.08.010, ISSN 2405-6545, pages 151 - 159, XP055764683
OPPOSITION- Aitoro R.; Paparo L.; Di Costanzo M.; Nocerino R.; Amoroso A.; Amato F.; Pirozzi C.; Calignano A.; Meli R.; Simeoli R.; Nagler C.; Guandalini S.; Berni C., "Breast milk butyrate as protective factor against food allergy", Digestive and Liver Disease, W.B. Saunders, GB, GB , (19000101), vol. 47, doi:10.1016/j.dld.2015.07.150, ISSN 1590-8658, XP029297038
OPPOSITION- Sacchi Raffaele, Paduano Antonello, Caporaso Nicola, Picariello Gianluca, Romano Raffaele, Addeo Francesco, "Assessment of milk fat content in fat blends by 13 C NMR spectroscopy analysis of butyrate", Food Control, BUTTERWORTH, LONDON, GB, GB , (20180901), vol. 91, doi:10.1016/j.foodcont.2018.04.011, ISSN 0956-7135, pages 231 - 236, XP093121449
OPPOSITION- Shiokawa, A. ; Tanabe, K. ; Tsuji, N.M. ; Sato, R. ; Hachimura, S., "IL-10 and IL-27 producing dendritic cells capable of enhancing IL-10 production of T cells are induced in oral tolerance", Immunology Letters, NL , (20090630), vol. 125, no. 1, doi:10.1016/j.imlet.2009.05.002, ISSN 0165-2478, pages 7 - 14, XP026301478
OPPOSITION- Albrecht Simone et al, "A comparative study of free oligosaccharides in the milk of domestic animals", British Journal of Nutrition, UK, UK , (20140414), vol. 111, no. 7, doi:10.1017/S0007114513003772, ISSN 0007-1145, pages 1313 - 1328, XP093119820
OPPOSITION- Albrecht Simone, Lane Jonathan A., Mariño Karina, Al Busadah Khalid A., Carrington Stephen D., Hickey Rita M., Rudd Pauline M., "A comparative study of free oligosaccharides in the milk of domestic animals", British Journal of Nutrition, UK, UK , (20140414), vol. 111, no. 7, doi:10.1017/S0007114513003772, ISSN 0007-1145, pages 1313 - 1328, XP093119820
OPPOSITION- Leong Andrea, Liu Zhiqian, Almshawit Hala, Zisu Bogdan, Pillidge Christopher, Rochfort Simone, Gill Harsharn, "Oligosaccharides in goats’ milk-based infant formula and their prebiotic and anti-infection properties", British Journal of Nutrition, UK, UK , (20190801), vol. 122, no. 04, doi:10.1017/S000711451900134X, ISSN 0007-1145, pages 441 - 449, XP093121447
OPPOSITION- Li, H. Chehade, M. Liu, W. Xiong, H. Mayer, L. Berin, M.C., "Allergen-IgE Complexes Trigger CD23-Dependent CCL20 Release From Human Intestinal Epithelial Cells", Gastroenterology, W.B. Saunders, (20071201), vol. 133, no. 6, doi:10.1053/j.gastro.2007.09.024, ISSN 0016-5085, pages 1905 - 1915, XP022380870
OPPOSITION- Alliet Philippe, Puccio Giuseppe, Janssens Elke, Cajozzo Cinzia, Corsello Giovanni, Berger Bernard, Sperisen Peter, Martin Francois-Pierre, Sprenger Norbert, Steenhout Philippe, "TERM INFANT FORMULA SUPPLEMENTED WITH HUMAN MILK OLIGOSACCHARIDES (2’FUCOSYLLACTOSE AND LACTO-NEOTETRAOSE) SHIFTS STOOM MICROBIOTA AND METABOLIC SIGNATURES CLOSER TO THAT OF BREASTFED INFANTS.", Journal of Pediatric Gastroenterology and Nutrition, Lippincott Williams Wilkins, Inc., US, US , (20160701), vol. 63, no. 1S, doi:10.1097/01.mpg.0000489632.17881.57, ISSN 0277-2116, page S55, XP093121740
OPPOSITION- Marriage et al., "Infants Fed a Lower Calorie Formula with 2'FL Show Growth and 2'FL Uptake Like Breast-Fed Infants", JPGN, (201512), vol. 61, doi:10.1097/MPG.0000000000000889, page 6, XP055271350
OPPOSITION- Diana L Oliveira; R Andrew Wilbey; Alistair S Grandison; Luísa B Roseiro, "Milk oligosaccharides: A review", INTERNATIONAL JOURNAL OF DAIRY TECHNOLOGY, SOCIETY OF DAIRY TECHNOLOGY, HUNTINGDON,, GB, GB , (20150628), vol. 68, no. 3, doi:10.1111/1471-0307.12209, ISSN 1364-727X, pages 305 - 321, XP072056820
OPPOSITION- Wang Yi, Yu Jinghua, "Membrane separation processes for enrichment of bovine and caprine milk oligosaccharides from dairy byproducts", Comprehensive Reviews in Food Science and Food Safety, Institute of food technologists , Chicago , IL, US, US , (20210701), vol. 20, no. 4, doi:10.1111/1541-4337.12758, ISSN 1541-4337, pages 3667 - 3689, XP093121743
OPPOSITION- S. Björkander; C. Carvalho‐Queiroz; J. Hallberg; J.‐O. Persson; M. A Johansson; B. Nussbaum; M. C Jenmalm; C. Nilsson; E. Sverremark‐Ekström, "Childhood allergy is preceded by an absence of gut lactobacilli species and higher levels of atopy‐related plasma chemokines", Clinical and experimental immunology, Wiley-Blackwell Publishing Ltd., GB, GB , (20200805), vol. 202, no. 3, doi:10.1111/cei.13494, ISSN 0009-9104, pages 288 - 299, XP071089955
OPPOSITION- Lee J. ‐s., Lee J. ‐y., Son J. W., Oh J. ‐h., Shin D. ‐m., Yuk J. ‐m., Song C. ‐h., Paik T. ‐h., Jo E. ‐k., "Expression and Regulation of the CC‐Chemokine Ligand 20 During Human Tuberculosis", SCANDINAVIAN JOURNAL OF IMMUNOLOGY, BLACKWELL SCIENCE PUBL., OXFORD, GB, GB , (20080101), vol. 67, no. 1, doi:10.1111/j.1365-3083.2007.02040.x, ISSN 0300-9475, pages 77 - 85, XP093248517
OPPOSITION- Yvonne M. Vissers, Johannes Snel, Peter F. Zuurendonk, Michiel Kleerebezem, Harry J. Wichers, Huub F.J. Savelkoul, "Lactobacillus strains differentially modulate cytokine production by hPBMC from pollen-allergic patients", FEMS Immunology & Medical Microbiology, No longer published by Elsevier, (20110219), vol. 61, no. 1, doi:10.1111/j.1574-695X.2010.00741.x, ISSN 09288244, pages 28 - 40, XP055068761
OPPOSITION- Holvoet Sébastien, Zuercher Adrian W., Julien-Javaux Françoise, Perrot Marie, Mercenier Annick, "Characterization of Candidate Anti-Allergic Probiotic Strains in a Model of Th2-Skewed Human Peripheral Blood Mononuclear Cells", International Archives of Allergy and Immunology, S. Karger, (20130101), vol. 161, no. 2, doi:10.1159/000343703, ISSN 1018-2438, pages 142 - 154, XP055810144
OPPOSITION- Filiz Yangilar, "As a potentially functional food: Goats' milk and products", Journal of Food and Nutrition Research, Science and Education Publishing, (20130101), vol. 1, doi:10.12691/jfnr-1-4-6, pages 68 - 81, XP093158461
OPPOSITION- Felicita Jirillo and Thea Magrone, "Anti-inflammatory and Anti-Allergic Properties of Donkey’s and Goat’s Milk", ENDOCRINE, METABOLIC & IMMUNE DISORDERS - DRUG TARGETS, BENTHAM SCIENCE PUBLISHERS LTD, BUSSUM, NL, NL , (20140101), vol. 14, no. 1, doi:10.2174/1871530314666140121143747, ISSN 1871-5303, pages 27 - 37, XP009551580
OPPOSITION- Park Curtis W.; Drake MaryAnne, "Condensed milk storage and evaporation affect the flavor of nonfat dry milk1", Journal of Dairy Science, American Dairy Science Association, US, US , (20160101), vol. 99, no. 12, doi:10.3168/jds.2016-11530, ISSN 0022-0302, pages 9586 - 9597, XP029815602
OPPOSITION- Parks O.W., Allen C., Cornell D.G., "Observations on Free Fatty Acids of Skim Milk", Journal of Dairy Science, American Dairy Science Association, US, US , (19770101), vol. 60, no. 1, doi:10.3168/jds.S0022-0302(77)83823-X, ISSN 0022-0302, pages 24 - 28, XP093121737
OPPOSITION- Rajani Puja S., Seppo Antti E., Järvinen Kirsi M., "Immunologically Active Components in Human Milk and Development of Atopic Disease, With Emphasis on Food Allergy, in the Pediatric Population", Frontiers in Pediatrics, Frontiers Research Foundation, CH, CH , vol. 6, doi:10.3389/fped.2018.00218, ISSN 2296-2360, XP093121742
OPPOSITION- Vandenplas Yvan et al, "A Partly Fermented Infant Formula with Postbiotics Including 3′-GL, Specific Oligosaccharides, 2′-FL, and Milk Fat Supports Adequate Growth, Is Safe and Well-Tolerated in Healthy Term Infants: A Double-Blind, Randomised, Controlled, Multi-Country Trial", Nutrients, vol. 12, no. 3560, doi:10.3390/nu12113560, pages 1 - 17, XP055844960
OPPOSITION- L. Peng, Z.-R. Li, R. S. Green, I. R. Holzman, J. Lin, "Butyrate Enhances the Intestinal Barrier by Facilitating Tight Junction Assembly via Activation of AMP-Activated Protein Kinase in Caco-2 Cell Monolayers", The Journal of Nutrition, American Society for Nutrition, US, US , (20090901), vol. 139, no. 9, doi:10.3945/jn.109.104638, ISSN 0022-3166, pages 1619 - 1625, XP055374908
OPPOSITION- David S Newburg, Ko J S, Leone S, Nanthakumar N N, "Human Milk Oligosaccharides and Synthetic Galactosyloligosaccharides Contain 3#-, 4-, and 6#-Galactosyllactose and Attenuate Inflammation in Human T84, NCM-460, and H4 Cells and Intestinal Tissue Ex Vivo", The Journal of Nutrition, American Society for Nutrition, US, US , (20160201), vol. 146, no. 2, doi:10.3945/jn.115.220749, ISSN 0022-3166, pages 358 - 367, XP055632669
OPPOSITION- Hong Gyong Hwa, Kwon Hyouk-Soo, Moon Keun-Ai, Park So Young, Park Sunjoo, Lee Kyoung Young, Ha Eun Hee, Kim Tae-Bum, Moon Hee-Bom, Lee Heung Kyu, Cho You Sook, "Clusterin Modulates Allergic Airway Inflammation by Attenuating CCL20-Mediated Dendritic Cell Recruitment", Journal of Immunology, Williams & Wilkins, (20160301), vol. 196, no. 5, doi:10.4049/jimmunol.1500747, ISSN 0022-1767, pages 2021 - 2030, XP093248513

Download Citation Report

Get a free citation report including examiner, opposition, and international search citations.

Get Citation Report

Dossier Documents

The dossier documents provide a comprehensive record of the patent’s prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent’s legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents